about
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...
Read More
219.61
1.60
(0.73%)
6.4M
XNYS Volume
XNYS 22 Jan, 2026 12:57 PM (EST)
Estimates Beat
J&J's Q4 revenue beats Forecaster estimates by 1.7%; projects 2026 revenue 1.8% above estimates
See details
High Financial Strength
Mid Valuation
Technically Moderately Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying
View Similar
Embed DVM
Johnson & Johnson Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..